502
Views
10
CrossRef citations to date
0
Altmetric
Author's View

Interleukin-2 treatment of tumor patients can expand regulatory T cells

Pages 1181-1182 | Received 27 Apr 2012, Accepted 04 May 2012, Published online: 01 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean-Marc Limacher, Xavier Preville, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch:. OncoImmunology 3:6.
Read now
Erika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:5.
Read now

Articles from other publishers (7)

Dae Young Lee, Eunji Im, Dahye Yoon, Young-Seob Lee, Geum-Soog Kim, Donghwi Kim & Sung-Hoon Kim. (2022) Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals. Seminars in Cancer Biology 86, pages 1033-1057.
Crossref
David Rafei-Shamsabadi, Saskia Lehr, Max Behrens & Frank Meiss. (2022) Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy. Cancers 14:3, pages 540.
Crossref
Chun-Chia Cheng, Hsin-Chi Lin, Ya-Wen Chiang, Jungshan Chang, Zong-Lin Sie, Bi-Ling Yang, Ken-Hong Lim, Cheng-Liang Peng, Ai-Sheng Ho & Yi-Fang Chang. (2020) Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression. Cancer Immunology, Immunotherapy 70:5, pages 1351-1364.
Crossref
Ju-Ha Kim, Jisung Hwang, Ji Hoon Jung, Hyo-Jung Lee, Dae Young Lee & Sung-Hoon Kim. (2019) Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression. Molecular Cancer 18:1.
Crossref
David Rafei-Shamsabadi, Saskia Lehr, Dagmar von Bubnoff & Frank Meiss. (2019) Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone. Cancer Immunology, Immunotherapy 68:9, pages 1417-1428.
Crossref
RUNLEI HU, SHENGLIN MA, XIANFU KE, HONG JIANG, DONGSHAN WEI & WEI WANG. (2016) Effect of interleukin-2 treatment combined with magnetic fluid hyperthermia on Lewis lung cancer-bearing mice. Biomedical Reports 4:1, pages 59-62.
Crossref
Anna Martner, Fredrik Bergh Thorén, Johan Aurelius & Kristoffer Hellstrand. (2013) Immunotherapeutic strategies for relapse control in acute myeloid leukemia. Blood Reviews 27:5, pages 209-216.
Crossref